颅内动静脉畸形立体定向放射外科治疗后颅内Masson病变
该回顾性病例系列报告了6例颅内动静脉畸形接受Leksell立体定向放射外科治疗后出现颅内Masson病变的患者,年龄28-56岁,周边剂量22-25 Gy,影像上出现明显强化肿块的时间为5-10年,其中4例因持续水肿和囊性增大行开颅切除后症状缓解。
要点
- 颅内AVM接受SRS后5-10年出现新强化肿块需警惕Masson病变。
- 本系列6例周边剂量22-25 Gy,4例因水肿和囊性增大行手术切除。
- 手术切除强化病变后患者症状得到缓解。
核心结论
- SRS是颅内AVM闭塞的有效治疗,但治疗后可能发生颅内Masson病变。
研究设计与样本
- 回顾性病例系列,共6例年龄28-56岁的颅内AVM患者,SRS后发生颅内Masson病变,复习影像、SRS记录及手术切除后神经病理标本。
主要发现
- 所有患者接受Leksell SRS,AVM周边剂量为22-25 Gy。
- 从SRS到影像上出现明显强化肿块的时间为5-10年。
- 4例因持续水肿和囊性增大行开颅切除强化病变,症状缓解。
临床怎么用
- 对SRS治疗AVM后5-10年出现新强化肿块伴水肿或囊性增大的患者,应考虑Masson病变可能。
- 对于持续水肿和囊性增大的Masson病变,开颅切除可缓解症状。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Masson tumor or intravascular papillary endothelial cell proliferation was first described in 1923. Only a few cases of intracranial Masson tumor have been reported following stereotactic radiosurgery (SRS). We report a series of 6 cases, age range 28-56 years, with intracranial Masson tumor following SRS for treatment of an intracranial arteriovenous malformation (AVM). METHODS: We performed a retrospective case note review, reviewed the imaging, SRS records, and neuropathology specimens following surgical excision. RESULTS: In our series all patients received Leksell SRS with the periphery of the AVM receiving doses ranging from 22-25 Gy. The time lapse from SRS to a clear enhancing mass appearing on imaging ranged from 5-10 years. Four patients underwent craniotomy and excision of the enhancing lesion for persistent edema and an enlarging cyst resulting in a resolution of symptoms. CONCLUSIONS: SRS is an effective treatment for obliteration of intracranial AVMs.
引用
- Roach J, Rossdeutsch A, Fabian M, et al. Intracranial Masson Lesion Following Stereotactic Radiosurgery for Treatment of Intracranial Arteriovenous Malformations. World Neurosurg. 2020. PMID: 32389876. doi:10.1016/j.wneu.2020.04.224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。